Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Conditions
Interventions
None listed
Sponsors
All India Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both gender aged 21 60 years willing to participate in the trial with chronicity of less than 5 years. Fulfilling the diagnostic criteria of Amavata/ Rheumatoid Arthritis (Seropositive Cases ) Patients having the clinical manifestation of Amavata (RA) according to Ayurvedic classics and contemporary sciences.
Exclusion criteria
Exclusion criteria: Patients with other systemic complications of RA. Patients with extra-articular manifestations are also excluded. Patients diagnosed with other arthritis like gouty arthritis tuberculous arthritis and psoriatic arthritis Patients with uncontrolled Hypertension (more than160/100 mm of Hg) Patients with uncontrolled Diabetes Mellitus (HbA1c more than 7% FBS more than 130 mg/dl) Patients who are allergic to any ingredient of Drugs Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Achievement of atleast 30% Reduction in CRP IL6 after intervention compared to baselineTimepoint: Baseline 0 day After treatment virechana and oral administration 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 30% Reduction in RA factor anti CCP ESR after intervention Significant improvement in the cardinal symptoms of Amavata (RA) 30% Reduction in DAS 28 Improvement in CBC. Improvement in the quality of life of Amavata patients by using SF36 Timepoint: Baseline 0 day After treatment virechana & oral administration 8 weeks t | — |
Countries
India
Contacts
Public ContactDr Rama Kant Yadava
All India Institute of Ayurveda
Outcome results
None listed